全文获取类型
收费全文 | 6669篇 |
免费 | 414篇 |
国内免费 | 273篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 94篇 |
妇产科学 | 76篇 |
基础医学 | 820篇 |
口腔科学 | 266篇 |
临床医学 | 622篇 |
内科学 | 1350篇 |
皮肤病学 | 114篇 |
神经病学 | 749篇 |
特种医学 | 122篇 |
外科学 | 399篇 |
综合类 | 974篇 |
现状与发展 | 3篇 |
预防医学 | 136篇 |
眼科学 | 124篇 |
药学 | 838篇 |
中国医学 | 200篇 |
肿瘤学 | 436篇 |
出版年
2024年 | 11篇 |
2023年 | 76篇 |
2022年 | 150篇 |
2021年 | 175篇 |
2020年 | 171篇 |
2019年 | 210篇 |
2018年 | 173篇 |
2017年 | 160篇 |
2016年 | 162篇 |
2015年 | 190篇 |
2014年 | 375篇 |
2013年 | 421篇 |
2012年 | 392篇 |
2011年 | 431篇 |
2010年 | 356篇 |
2009年 | 351篇 |
2008年 | 395篇 |
2007年 | 377篇 |
2006年 | 394篇 |
2005年 | 373篇 |
2004年 | 270篇 |
2003年 | 237篇 |
2002年 | 192篇 |
2001年 | 162篇 |
2000年 | 136篇 |
1999年 | 127篇 |
1998年 | 101篇 |
1997年 | 97篇 |
1996年 | 76篇 |
1995年 | 75篇 |
1994年 | 84篇 |
1993年 | 59篇 |
1992年 | 41篇 |
1991年 | 54篇 |
1990年 | 37篇 |
1989年 | 26篇 |
1988年 | 28篇 |
1987年 | 25篇 |
1986年 | 15篇 |
1985年 | 42篇 |
1984年 | 37篇 |
1983年 | 19篇 |
1982年 | 24篇 |
1981年 | 15篇 |
1980年 | 17篇 |
1979年 | 7篇 |
1977年 | 2篇 |
1974年 | 1篇 |
1972年 | 3篇 |
1970年 | 2篇 |
排序方式: 共有7356条查询结果,搜索用时 31 毫秒
151.
Roberto Schreiber Cristiane M. Souza Layde R. Paim Guilherme de Rossi José R. Matos-Souza Anselmo de A. Costa e Silva Fernando R. Faria Eliza R. Azevedo Karina C. Alonso Andrei C. Sposito Alberto Cliquet José I. Gorla Wilson Nadruz 《Archives of physical medicine and rehabilitation》2018,99(8):1561-1567.e1
Objective
To investigate the relationship of carotid artery intima-media thickness (IMT) and cardiac structure and function with adipocytokines in sedentary (S-SCI) and physically active (PA-SCI) subjects with spinal cord injury (SCI).Design
Cross-sectional observational study.Setting
Academic medical center.Participants
Men with chronic (>1y) SCI (N=41; 16 S-SCI, 25 PA-SCI) were evaluated. S-SCI subjects did not perform labor that required physical effort, recreational physical activity, or sports, while PA-SCI subjects included competing athletes who were regularly performing adapted sports.Interventions
Not applicable.Main Outcome Measures
Clinical, laboratory, carotid ultrasonography, and echocardiography analysis. Plasma leptin, adiponectin, and plasminogen activating inhibitor-1 (PAI-1) levels were determined.Results
PA-SCI subjects had similar levels of adipocytokines, but lower carotid IMT and carotid IMT/diameter, and better left ventricular diastolic function than S-SCI participants. Bivariate analysis showed that adiponectin was inversely correlated with triglycerides (r=–.85, P<.001), low-density lipoprotein cholesterol (r=–.57, P<.05), and carotid IMT/diameter (r=–.56, P<.05) in S-SCI but not in PA-SCI participants. Additionally, the leptin-adiponectin ratio showed a direct correlation with triglycerides (r=.84, P<.001) and low-density lipoprotein cholesterol (r=.53, P<.05) in S-SCI but not in PA-SCI individuals. By contrast, the studied adipocytokines did not correlate with cardiac structure and function in PA-SCI and S-SCI participants.Conclusions
Lower adiponectin levels and higher leptin-adiponectin ratio are related to adverse vascular and/or metabolic characteristics in individuals with SCI. This relationship, however, appears to be mitigated by regular physical activity. 相似文献152.
目的探讨估算的肾小球滤过率(eGFR)、血尿酸(SUA)、纤维蛋白原(FIB)与缺血性脑卒中溶栓后脑出血转化及临床结局的关系。方法选取158例缺血性脑卒中用重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓患者,包括无脑出血转化121例、脑出血转化37例。采用Logistic回归方程分析rt-PA静脉溶栓后脑出血转化影响因素;对比不同早期神经功能患者eGFR、SUA、FIB水平;评价eGFR、SUA、FIB对早期神经功能恶化(END)的预测价值;比较不同eGFR、SUA、FIB水平患者的累积生存率。结果rt-PA静脉溶栓2 h、24 h后,脑出血转化者eGFR、SUA、FIB水平较无脑出血转化者降低(P<0.05)。Logistic回归分析显示,年龄、基线NIHSS评分、基线舒张压、大面积脑梗死及溶栓后2 h和24 h的eGFR、SUA、FIB均为rt-PA静脉溶栓后脑出血转化的影响因素(P<0.05)。END患者溶栓后2 h和24 h的eGFR、SUA、FIB均低于非END患者(P<0.05)。ROC曲线分析显示,溶栓后24 h的eGFR、SUA、FIB联合预测END的曲线下面积为0.809,大于任一单一指标,其灵敏度、特异度分别为80.95%、74.14%。生存分析结果表明,溶栓后24 h的eGFR、SUA、FIB高水平组的累积生存率高于低水平组(P<0.05)。结论eGFR、SUA、FIB与缺血性脑卒中预后密切相关,监测上述指标有助于脑出血转化诊断及END预测。 相似文献
153.
梁雪珍 《临床合理用药杂志》2015,(6):9-10,12
目的:研究尿激酶治疗血栓栓塞性疾病的临床效果。方法选取湛江市第二中医医院2012年6月—2014年6月收治的195例血栓栓塞性疾病患者,根据治疗方法不同分为两组,111例采用尿激酶治疗的患者设为尿激酶组,84例采用低分子肝素治疗的患者设为肝素组,比较两组效果和不良反应。结果尿激酶组肺栓塞( PE)患者总有效率为78.44%,深静脉血栓形成( DVT)患者总有效率为96.67%;肝素组 PE患者总有效率为60.98%, DVT患者总有效率为81.40%。两组比较差异有统计学意义( P<0.05)。治疗后2周尿激酶组膝下15cm和膝上15cm健、患肢周径差均小于肝素组( P<0.05)。尿激酶组不良反应发生率为5.41%,肝素组为2.38%,无黏膜或其他脏器出血病例,两组不良反应发生率比较,差异无统计学意义( P>0.05)。结论尿激酶溶栓可提高血栓栓塞性疾病患者的疗效,且不良反应少。 相似文献
154.
155.
Ercan E Tengiz I Duman C Sekuri C Aliyev E Mutlu B Ercan HE Akin M 《Journal of thrombosis and thrombolysis》2004,17(3):207-211
BACKGROUND: Matrix metalloproteinases (MMPs) have been implicated in the pathogenesis of arterial aneurysms through increased proteolysis of extracellular matrix proteins. Increased proteolysis due to elevated matrix degrading enzyme activity in the arterial wall may act as a susceptibility factor for the development of coronary aneurysms. Plasmin strongly stimulates pro-MMP enzyme conversion to the active form. Plasmin hyperactivity due to decreased plasminogen activator inhibitor-1 (PAI-1) may cause MMP over activity and coronary aneurysms. The aim of this study was to investigate the association between PAI-1 and presence of coronary aneurysms. METHODS: Twenty-three patients with aneurysmal coronary artery disease and stable angina were enrolled into study (Group 1). Twenty-two patients without coronary aneurysm were selected as a control group (Group 2). PAI-1 was measured in peripheral venous blood. RESULTS: The plasma PAI-1 level was lower in the coronary artery aneurysmatic patients compared to the control group (8.41 +/- 4.28 vs. 13.32 +/- 10.05 ng/ml, p = 0.037). Serum C-reactive protein (CRP) values were not significantly different between groups (3.83 +/- 1.08 vs. 4.01 +/- 1.35 mg/l, p >0.05). CONCLUSION: Increased matrix degrading enzyme activity can cause arterial wall destruction through increased proteolysis of extracellular matrix proteins. Unregulated plasmin hyperactivity due to decreased inhibition by PAI-1 may play an important role in coronary aneurysm formation. 相似文献
156.
肝硬化患者血浆中尿激酶型纤溶酶激活物的检测及其意义 总被引:4,自引:0,他引:4
目的 探讨肝硬化患者血浆尿激酶型纤溶酶激活物(uPA)、尿激酶型纤溶酶激活物受体(uPAR)、纤溶酶原激活物抑制剂-1(PAI-1)的变化及其意义。 方法 确诊的72例乙型肝炎后肝硬化患者,Child-pugh分级A级23例(A组),B级29例(B组),C级20例(C组)。6例健康志愿献血者为正常对照组。酶联免疫吸附实验测定血浆uPA、uPAR、PAI-1的变化。并同时检测血透明质酸(HA)、Ⅳ型胶原(C Ⅳ)、Ⅲ型前胶原(PC Ⅲ)、血浆白蛋白、胆红素、凝血酶原时间及其活动度改变。 结果 随着肝硬化的进展,血浆uPA、uPAR、PAI-1逐渐增加,HA、PC Ⅲ也明显增加。Child C组患者血浆uPA、uPAR、PAI-1水平(μg/L)分别为1.88±0.64、4.82±2.02和52.60±16.87,A组分别为1.36±0.43、3.03±1.48和24.09±7.14,B组分别为1.79±0.62、4.80±2.22和41.40±17.52,C组与A、B组比较,t值为2.81~7.38,P值均<0.01。A组血浆uPA与PC Ⅲ呈负相关(r=-0.4785,P<0.05);C组PAI-1与HA呈正相关(r=0.5447,P<0.01)。 结论 肝硬化晚期,虽然血浆uPA、PAI-1增加,但总的效应表现为uPA相对不足,肝基质纤维降解受抑制,血浆uPA、PAI-1与肝硬化发展密切相关。 相似文献
158.
159.
Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy 总被引:1,自引:0,他引:1
M Saito H Asakura H Jokaji C Uotani I Kumabashiri K Ito T Matsuda 《American journal of hematology》1989,32(1):20-23
Hemostatic changes were evaluated in ten patients with acute lymphoblastic leukemia and lymphoma who received chemotherapy with L-asparaginase, vincristine, and prednisolone for 1 week. Following treatment, prothrombin time and activated partial thromboplastin time were significantly prolonged, while a marked decrease in fibrinogen levels was observed. The values for cross-linked fibrin degradation products, however, remained within normal limits during treatment, which excluded the possibility of disseminated intravascular coagulation. The concentrations of coagulation inhibitors (antithrombin III, protein C, and protein S), plasminogen, and alpha 2 antiplasmin also significantly decreased; however, levels of both tissue-type plasminogen activator and plasminogen activator inhibitor, which are synthesized in endothelial cells, increased during the treatment. Although a decrease was observed in concentrations of many coagulation factors, including subunits A and B of factor XIII, the activity and antigenicity of factor VII significantly increased following the treatment. From this study, we concluded that these hemostatic abnormalities caused by the administration of L-asparaginase produced a labile condition that easily inclines to bleeding or thrombosis. 相似文献
160.
Politou M Terpos E Anagnostopoulos A Szydlo R Laffan M Layton M Apperley JF Dimopoulos MA Rahemtulla A 《British journal of haematology》2004,126(5):686-689
The aim of this study was to evaluate the role of markers of bone remodelling, and osteoclast activation/function in patients with monoclonal gammopathy of undetermined significance (MGUS). We have measured serum levels of soluble RANKL (sRANKL), osteoprotegerin (OPG), macrophage inflammatory protein-1alpha (MIP-1alpha), markers of bone resorption [N-telopeptide of collagen type-I (NTX), and tartrate-resistant acid phosphatase isoform-5b (TRACP-5b)] and bone formation [bone-alkaline phosphatase (bALP)] in 40 MGUS patients. These parameters were compared with those of 42 newly diagnosed myeloma patients, and 45 healthy, gender- and age-matched controls. MGUS patients had elevated levels of NTX, sRANKL, and sRANKL/OPG ratio compared with controls (P < 0.0001). Furthermore, TRACP-5b, MIP-1alpha and NTX were decreased in patients with MGUS compared with myeloma patients (P < 0.001), while OPG and bALP were increased (P < 0.001). Serum levels of MIP-1alpha, as well as TRACP-5b, and sRANKL/OPG ratio were reduced, while bALP was increased in MGUS patients, even when compared with myeloma patients who had stage I/II disease. These results demonstrate that increased osteoclastogenesis leading to increased bone resorption is present in MGUS but seems to be compensated for by normal bone formation, which is absent in MM. Furthermore MIP-1alpha, bALP, and sRANKL/OPG may be useful tools for distinguishing between cases of MGUS and early myeloma. 相似文献